% | $
Quotes you view appear here for quick access.

Immune Pharmaceuticals, Inc. Message Board

  • dctrig dctrig Nov 30, 2010 12:32 PM Flag

    EPCT Could Soon Have an Icagen Move

    EPCT's pain cream could soon find a partner.

    ICGN up 80% today!

    Icagen, Inc. (Nasdaq:ICGN) today provided an update on its sodium channel program for pain and related disorders which is being conducted in collaboration with Pfizer. As previously reported, the companies recently conducted a clinical study in healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7. Based upon data obtained in this study, the companies have now selected one of these compounds to advance into further clinical studies. The selection of this compound has triggered a milestone payment to Icagen of $1.0 million.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
0.3864-0.0036(-0.92%)11:11 AMEDT